SCHEMBL3276060

SCHEMBL3276060

NC(=S)NN=C1C(O)=CC(=O)c2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.63
▸ KMT2A Q03164 5/20 0.63
▸ GAA P10253 2/20 0.63
▸ PABPC1 P11940 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ PTPN22 Q9Y2R2 1/20 0.39
▸ TDP1 Q9NUW8 4/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ KCNH2 Q12809 1/20 0.35
▸ ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16210519 0.78 KMT2A (1.00) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL28047900 0.74 MEN1 (0.59) MEN1KMT2AGAAPABPC1MAPT
SCHEMBL3277278 0.73 MEN1 (0.58) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL3276058 0.73 KMT2A (0.50) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL3077569 0.72 KMT2A (0.53) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL10084821 0.70 KMT2A (0.58) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL98437 0.70 KMT2A (0.58) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL19586520 0.69 KMT2A (0.57) MEN1KMT2AGAAMAPTALDH1A1
SCHEMBL9915565 0.68 MAPT (0.74) MEN1KMT2AGAAPABPC1RXFP1
SCHEMBL19059582 0.68 MEN1 (0.69) MEN1KMT2AGAAPABPC1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691418-B2 Composition for inhibiting or preventing the formation of a biofilm OYSTERSHELL NV (BE) 2010-04-06 — — US disclosed
US-20070258913-A1 Composition for Inhibiting or Preventing the Formation of a Biofilm OYSTERSHELL NV (BE) 2007-11-08 — — US disclosed
EP-1796656-A2 COMPOSITION FOR INHIBITING OR PREVENTING THE FORMATION OF A BIOFILM Oystershell NV (BE) 2007-06-20 — — EP disclosed
WO-2006029893-A2 COMPOSITION FOR INHIBITING OR PREVENTING THE FORMATION OF A BIOFILM OYSTERSHELL NV (BE) 2006-03-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258913-A1 Composition for Inhibiting or Preventing the Formation of a Biofilm NQO2, NFKBIA, CROCC MEN1 3614/4885KMT2A 3594/4885GAA 737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback